|
Market Closed -
London S.E.
18:35:16 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 11,970.00 GBX | -1.19% |
|
-2.21% | -13.20% |
| 09:44am | AstraZeneca, Daiichi Sankyo's Breast Cancer Treatment Combo Wins EU Nod | MT |
| 09:20am | AstraZeneca lung cancer therapy combination shows promise in advanced study | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 212.66 | +31.03% | 22 | ||||||
| 1,315.04 | +13.69% | 29 | ||||||
| 272.5 | +2.5% | 22 | ||||||
| 276.59 | +7.86% | 29 | ||||||
| 370.31 | +4.96% | 18 | ||||||
| 154.32 | +1.22% | 21 | ||||||
| 388.48 | -9.63% | 29 | ||||||
| 309.73 | +5.93% | 23 | ||||||
| 157.41 | +7.56% | 27 | ||||||
| 28.61 | +0.51% | 26 | ||||||
| 563.12 | +3.42% | 25 | ||||||
| 66.21 | -0.9% | 24 | ||||||
| 94.28 | +22.74% | 23 | ||||||
| 21.69 | +17.01% | 20 | ||||||
| 9,350 | +35.25% | 15 | ||||||
| 6,547.06 | +13.57% | 16 | ||||||
| 57.39 | +17.02% | 18 | ||||||
| 71.74 | +55.71% | 17 | ||||||
| 4.214 | +14.45% | 17 | ||||||
| 41.4 | +14.84% | 10 | ||||||
| Average | 1,015.14 | +12.94% | 22 | ||||||
| Weighted average by Cap. | 701.38 | +9.17% | 24 |
- Stock Market
- Stocks
- AZN Stock
- Sector AstraZeneca PLC
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
